Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Sexual health news

Show

From To
Inside Grindr, fears that China wanted to access user data via HIV research

Just a few months after a Chinese gaming company acquired Grindr, a gay dating app, employees of the app learned that the Trump administration was investigating the deal over national security concerns, according to two people familiar with the company. There were worries that China could harvest potentially embarrassing or sensitive private data from the app for espionage purposes. For example, China might be able to find out the HIV status of U.S. military or security personnel who use Grindr.

Published
05 April 2019
From
NBC News
Efavirenz and rifampicin together reduce levels of injectable contraception

Women with HIV receiving depot medroxyprogesterone acetate (DMPA), with efavirenz (EFV)-based ART and rifampicin (RIF)-based TB treatment, had lower MPA plasma levels compared with women not receiving the two drugs.

Published
29 March 2019
From
HIV i-Base
Double-dose levonorgestrel implant does not overcome interaction with efavirenz

Using two levonorgestrel (LNG) implants does not fully overcome the drug-drug interaction with efavirenz (EFV) – according to findings from a pharmacokinetic (PK) evaluation of double-dose LNG in Ugandan women receiving EFV-based ART.

Published
29 March 2019
From
HIV i-Base
Reclaiming my time!

Every time I take my medicine, it is an act of preventing transmission, and survival. Never again will I see myself as ‘unclean’ or ‘a risk to others’. The only time HIV plays a role in my life is when I take my medication before bed.

Published
22 March 2019
From
PrEPing MALTA
Pipeline for Gonorrhea, Chlamydia, and Syphilis

A new report on the sexually transmitted infection (STI) treatment and prevention research “pipeline” points to serious gaps in the development of new tools to address a growing epidemic in the U.S. The report, released today by Treatment Action Group (TAG), provides an assessment of the current research pipeline and calls for a major new investment in STI research.

Published
20 March 2019
From
TAG
Sex clinics show how competition can improve England’s NHS

Patients can walk into clinics without a referral, so providers have to compete for their business.

Published
15 March 2019
From
The Economist (requires free registration)
Women Have High Syphilis Rates, Too

For women in the general population, the incidence of syphilis is at a 20-year high. But for women with HIV — particularly those who inject drugs — the incidence is 330% higher than that, data from a long-term study show. The biggest indicators of syphilis in women are hepatitis C infection and injection drug use. This means that providers should tailor syphilis screening to women with indicators of injection drug use, particularly in regions of the country hardest hit by injection drug epidemics.

Published
11 March 2019
From
Medscape (requires free registration)
Why are black and minority ethnic girls less likely to get the HPV jab? (Video)

The HPV - or Human Papilloma Virus - vaccine is available to year 8 and 9 schoolgirls across Britain. But not all of them get the jab. Girls from black, Asian or minority ethnic (BAME) backgrounds are less likely to receive the vaccine in school than their white counterparts.

Published
04 March 2019
From
BBC
Illegal STI drugs being sold online

Unlicensed antibiotics are being advertised on social media as treatment for sexually transmitted infections and sold at the wrong dose.

Published
04 March 2019
From
BBC Health
Gonorrhoea: drug resistance compromises recommended treatment in Europe

In 2017, 27 EU/EEA countries collected and tested 3 248 gonococcal isolates which revealed that cefixime and azithromycin resistance (1.9% and 7.5% respectively) remained unchanged compared to 2016 (2.1% and 7.5%). However, the number of countries reporting resistant isolates for each antimicrobial increased. For the second year in a row, no isolates with resistance to ceftriaxone were detected in contrast to one in 2015, five in 2014 and seven in 2013.

Published
28 February 2019
From
ECDC
← First12345...59Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.